AdaptHealth extends interim CEO Barasch through Oct 31; new CEO Teufel delayed by court order

AdaptHealth Corp.

Richard Barasch extends interim CEO term to Oct 31, 2023 with $262,500/month base salary and $175K RSU grant.
Court TRO bars incoming CEO Crispin Teufel from starting until Oct 15, 2023 due to Linde Group lawsuit over confidential info.
Preliminary injunction hearing scheduled for Oct 18, 2023; AdaptHealth is not a defendant in the case.
Teufel was appointed CEO effective Sept 1, 2023; start now delayed by 45 days pending court order.
Barasch's prior RSUs ($175K) vest Aug 31, 2023; new RSUs granted Sept 1 vest on Transition Date.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change (interim)

Richard Barasch

Interim Chief Executive Officer

AHCO · AdaptHealth Corp.

Effective: 2023-09-01
Filed: August 29, 2023, 7:59 PM ET

Mr. Barasch has agreed to continue to serve as the Interim Chief Executive Officer of the Company until October 31, 2023 or such earlier date as determined by the Board of Directors of the Company (the “Transition Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.85

Richard Barasch changed role as Interim Chief Executive Officer at AdaptHealth Corp..

Action: continued service as interim CEO
Role: Interim Chief Executive Officer

Exact text from the filing

Mr. Barasch has agreed to continue to serve as the Interim Chief Executive Officer of the Company until October 31, 2023 or such earlier date as determined by the Board of Directors of the Company (the “Transition Date”).

View on SEC.gov

AdaptHealth Corp. filing history →

Source: SEC EDGAR

accession 0001104659-23-096404

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.